A significant discussion on the synergies in research and production of pharmaceutical and biotechnological products was recently held, organized by the Non-Profit Civil Partenership Komvos-Node: Networks of Global Hellenism in collaboration with the ARISTEiA Institute. The discussion was moderated by Professor Konstantinos Drosatos – General Secretary of Kómvos and President of ARISTEiA-Institute for the Advancement of Research & Education in Arts, Sciences, and Technology, and Professor at the College of Medicine, University of Cincinnati.
Participants in the Discussion:
The discussion was enriched by presentations from notable figures in the fields of science and biotechnology, including:
- Dr. Nikos Kyrpides
Senior Staff Scientist, Berkeley National Laboratory, USA
Head of the Prokaryote Super Program, Department of Energy Joint Genome Institute, USA
Member of the Board of Directors of Kómvos.
- Professor Simos Symeonidis
Founder and CEO, Kos Biotechnology Partners, USA.
- Vassia Tegoulia
Senior Director, Pharmaceutical Development, Genentech, USA.
The Significance of the Discussion for Greece
The discussion was particularly significant for Greece as it highlighted the long-standing tradition, and the successes of Greek scientists, both in Greece and abroad. Participants showcased how Greece can leverage its strengths and tap into the global pharmaceutical market, a market projected to reach $1 trillion by 2030.
Greece already has pharmaceutical and biotechnology companies among the top 10 in Europe, and it has the potential to exploit the global demand by offering the knowledge and technological advancements of Greek scientists worldwide.
The discussion addressed crucial topics such as the convergence of research and production, the utilization of technological and scientific achievements, and strategies for developing Greece’s pharmaceutical and biotechnology industries.
Watch the full discussion here:
